ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Philadelphia, PA, USA:

A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease (COORDINATE)

COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...

Active, not recruiting
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Other: Intense Education Intervention
Duke University
Duke University

Sewell, New Jersey, United States and 43 other locations

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

Philadelphia, Pennsylvania, United States and 9 other locations

Pregnant women aged 18-49 with gestational diabetes (GDM) will take part in this study. We want to see how two different insulin treatments ...

Not yet enrolling
Diabetes, Gestational
Pregnancy Complications
Drug: Inhaled Technosphere Insulin

Phase 2, Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

Philadelphia, Pennsylvania, United States and 4 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Philadelphia, Pennsylvania, United States and 64 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 89 other locations

preserving beta-cell function and delaying the progression of type 1 diabetes (T1D) in adolescent and adult patients. The safety of ladarixi...

Active, not recruiting
New-onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 3

Dompé
Dompé

Philadelphia, Pennsylvania, United States and 56 other locations

Locations recently updated

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Philadelphia, Pennsylvania, United States and 175 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 652 other locations

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....

Enrolling
Type 1 Diabetes
Drug: VX-264

Phase 1, Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Philadelphia, Pennsylvania, United States and 14 other locations

it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...

Not yet enrolling
Type 2 Diabetes Mellitus
Drug: LY3209590

Phase 1

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems